Clinical Trials for EBV-Positive Diffuse Large B-Cell Lymphoma, Nos

Find clinical trials for ebv-positive diffuse large b-cell lymphoma, nos. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS

NCT ID: NCT06925555

This clinical trial is investigating a new treatment option for patients diagnosed with a specific type of lymphoma called EBV-Positive Diffuse Large B-Cell Lymphoma (DLBCL). The treatment involves...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Nanjing, Jiangsu, China

Selinexor in Combination With R-CHOP Followed by Selinexor Maintenance for Untreated EBV-positive DLBCL Patients

NCT ID: NCT05577364

This clinical trial is studying a new treatment combination for patients with untreated EBV-positive diffuse large B-cell lymphoma (DLBCL), a type of blood cancer. The researchers want to see how w...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, , China, Shanghai, Shanghai, China +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions